FOLH1 and prostate cancer: In this work, only patients scanned with F18‐FDG were included in the research protocol, and future work should investigate the performance of the CBM_DDG algorithm with radiotracers that are gaining more widespread use clinically such as Ga‐68 DOTATATE for neuroendocrine studies and F18‐Fluciclovine or PSMA labeled agents for prostate cancer.